EBV Early Antigen

Product Overview

GST-fused HHV-4 Early Antigen Type D, C-terminus regions amino acids 306-390

Nature

Recombinant

Tag/Conjugate

Unconjugated

Purity

> 95%, based on SDS PAGE

Format

Each vial contains 100 μg of lyophilized protein in 50mM Tris-HCl, 10mM glutation, 60mM NaCl, 0.5% sarcosyl and 50% glycerol.

Concentration

N/A

Preservative

None

Storage

2-8°C short term, -20°C long term

Introduction

The Epstein–Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is a virus of the herpes family and is one of the most common viruses in humans. It is best known as the cause of infectious mononucleosis (glandular fever). It is also associated with particular forms of cancer, such as Hodgkin's lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma, and central nervous system lymphomas associated with HIV. There is evidence that infection with the virus is associated with a higher risk of certain autoimmune diseases, especially dermatomyositis, systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis. Infection with EBV occurs by the oral transfer of saliva

Keywords

Epstein–Barr virus; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus; Human herpesvirus 4; HHV-4; EBV; EBV Early Antigen; Epstein–Barr virus Early Antigen; HHV-4 Early Antigen; Human herpesvirus 4 Early Antigen